|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1994-9-30
|
|
pubmed:abstractText |
In chronic hepatitis C, interferon alfa (IFN-alpha) therapy fails to achieve a sustained response in approximately 75% of patients. Similarly, ribavirin induces only a transient response. The aim of this study was to evaluate whether ribavirin and IFN-alpha in combination could be effective in IFN-alpha-resistant chronic hepatitis C.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
812-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7521308-Adult,
pubmed-meshheading:7521308-Alanine Transaminase,
pubmed-meshheading:7521308-Chronic Disease,
pubmed-meshheading:7521308-Drug Resistance, Microbial,
pubmed-meshheading:7521308-Drug Therapy, Combination,
pubmed-meshheading:7521308-Female,
pubmed-meshheading:7521308-Hepacivirus,
pubmed-meshheading:7521308-Hepatitis C,
pubmed-meshheading:7521308-Humans,
pubmed-meshheading:7521308-Interferon-alpha,
pubmed-meshheading:7521308-Liver,
pubmed-meshheading:7521308-Male,
pubmed-meshheading:7521308-Middle Aged,
pubmed-meshheading:7521308-Pilot Projects,
pubmed-meshheading:7521308-RNA,
pubmed-meshheading:7521308-Ribavirin
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.
|
|
pubmed:affiliation |
Department of Internal Medicine and Gastroenterology, University of Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
